| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.12B | 124.76B | 122.00B | 138.49B | 155.11B | 170.39B |
| Gross Profit | 25.98B | 25.22B | 21.31B | 22.22B | 23.78B | 28.66B |
| EBITDA | 14.04B | 19.54B | 8.87B | 13.52B | 9.57B | 9.89B |
| Net Income | 11.26B | 10.29B | 2.01B | 6.34B | 3.98B | 3.88B |
Balance Sheet | ||||||
| Total Assets | 196.87B | 196.78B | 192.76B | 197.72B | 187.30B | 190.70B |
| Cash, Cash Equivalents and Short-Term Investments | 22.45B | 24.25B | 24.76B | 36.65B | 29.91B | 23.52B |
| Total Debt | 20.83B | 21.04B | 31.00B | 42.70B | 41.73B | 42.97B |
| Total Liabilities | 67.55B | 66.28B | 78.47B | 94.06B | 91.62B | 94.65B |
| Stockholders Equity | 127.00B | 128.01B | 112.06B | 101.90B | 93.80B | 94.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.27B | -2.24B | 4.26B | 6.98B | -7.90B |
| Operating Cash Flow | 0.00 | 4.17B | 3.00B | 11.52B | 12.83B | 266.00M |
| Investing Cash Flow | 0.00 | 1.42B | -2.19B | -3.77B | -3.55B | -6.92B |
| Financing Cash Flow | 0.00 | -7.00B | -3.84B | -358.00M | -3.03B | -1.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥134.02B | 11.39 | ― | 3.72% | 5.40% | 14.80% | |
76 Outperform | ¥90.80B | 12.64 | ― | 3.04% | 1.57% | -33.97% | |
74 Outperform | ¥42.32B | 5.50 | ― | 3.70% | 14.83% | 51.42% | |
71 Outperform | ¥24.68B | 10.51 | ― | 3.61% | 8.85% | 110.05% | |
70 Outperform | ¥65.80B | 15.82 | ― | 4.37% | -1.09% | ― | |
66 Neutral | ¥7.58B | -8.15 | ― | 2.84% | 37.67% | -117.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |